# Phase 1 Uterine Cervical cancer trials recruiting: 39 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 39 trials in phase 1 for Uterine Cervical cancer that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting Phase 1 Uterine Cervical cancer trials: 39 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/phase-1/uterine-cervical-neoplasms

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 39
- Recruiting or not yet: 39
- Read on: November 19, 2026

## Trials

The 25 newest of 39, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 18, 2026 | NCT07947043 | Exploratory Clinical Study of Autologous Tumor-Infiltrating Lymphocytes (TIL) Injection | Tongji Hospital | Phase 1 | Recruiting | Recurrent or Metastatic Lung Cancer or Cervical Cancer | 18 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07947043) |
| June 17, 2026 | NCT07653503 | Neoadjuvant Lymph Node Targeted Immunotherapy in Cervical Cancer: a Feasibility Study (NEOLYNC) | University Medical Center Groningen | Phase 1 | Recruiting | Cervical Carcinoma | 12 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07653503) |
| June 3, 2026 | NCT07623369 | A First-in-Human Study of HH160 in Participants With Advanced or Metastatic Solid Tumors | Huahui Health | Phase 1 | Recruiting | Solid Tumor, Non-small Cell Lung Cancer, Hepatocellular Carcinoma, Colorectal Cancer, Head and Neck Squamous Cell... | 299 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07623369) |
| April 13, 2026 | NCT07524322 | Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors | Regor Pharmaceuticals Inc. | Phase 1 | Recruiting | Breast Cancer, Ovarian Cancer, Endometrial Cancer, PIK3CA Mutation, HER2- Negative Breast Cancer, Advanced Breast... | 63 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07524322) |
| December 18, 2025 | NCT07292818 | Hyaluronic Acid-based Gel Spacers in Gynecologic Malignancies | UNC Lineberger Comprehensive Cancer Center | Phase 1 | Recruiting | Cervix Cancer | 14 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07292818) |
| November 14, 2025 | NCT07229313 | A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors | Kivu Bioscience Inc. | Phase 1 | Recruiting | Advance Solid Tumors | 76 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07229313) |
| November 12, 2025 | NCT07227168 | A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer | Sutro Biopharma, Inc. | Phase 1 | Recruiting | Head and Neck Squamous Cell Carcinoma HNSCC, Non-Small Cell Lung Cancer NSCLC, Esophageal Cancer, Gastric Cancer... | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07227168) |
| September 19, 2025 | NCT07182149 | A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors | Normunity AccelCo, Inc. | Phase 1 | Recruiting | HNSCC, ESCC, Esophageal Adenocarcinoma, Gastric Adenocarcinoma, GEJ Adenocarcinoma, Ovarian Cancer, NSCLC, Cervical... | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07182149) |
| July 24, 2025 | NCT07081984 | Study of TI-0093 Injection With Recurrent/Metastatic HPV-16 Positive Solid Tumors | Therorna | Phase 1 | Recruiting | HPV 16+ Recurrent or Metastatic Cancer, HNSCC, Cervical Cancer | 12 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07081984) |
| May 31, 2025 | NCT06999187 | A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas | Sponsor not shown (see the record) | Phase 1 | Recruiting | Triple Negative Breast Cancer, HER2-negative Breast Cancer, Non Small Cell Lung Cancer, Cervical Cancer, Castrate... | 96 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06999187) |
| April 4, 2025 | NCT06910657 | IDOV-Immune for Advanced Solid Tumors | ViroMissile, Inc. | Phase 1 | Recruiting | Colorectal Cancer, Pancreatic Cancer, Melanoma, Ovarian Cancer, Gastric Cancer, Esophageal Cancer, Hepatocellular... | 78 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06910657) |
| January 7, 2025 | NCT06760676 | A Multiple Tumor Species, Open and Multi-center Clinical Study of Alpaloritovorelli Antibodies (QL-1706) Combined with Pulsed Low Dose Rate... | Anhui Provincial Hospital | Phase 1 | Not yet recruiting | Esophageal Cancer, Non Small Cell Lung Cancer, Cervical Cancer | 90 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06760676) |
| August 14, 2024 | NCT06552598 | The Safety, Tolerability, and Efficacy of KD01 in Gynecologic Malignancies | Tongji Hospital | Phase 1 | Recruiting | Cervical Cancer, Gynecologic Malignancies, Endometrial Cancer | 97 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06552598) |
| August 9, 2024 | NCT06544720 | SCG142 TCR-T Cells for Human Papillomavirus-Associated Carcinomas | The Affiliated Hospital of Qingdao University | Phase 1 | Recruiting | Human Papillomavirus Associated Carcinomas, Cervical Cancer, Head and Neck Cancers, Anal Cancer, Vulva Cancer, Vaginal... | 18 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06544720) |
| July 18, 2024 | NCT06508307 | A Phase I Clinical Study of Intratumoral Injection Oncolytic Vaccinia Virus GC001 in Patient With Advanced Solid Tumors | GONGCHU Biotechnology Co., Ltd | Phase 1 | Recruiting | Sarcoma, Cervical Cancer, Colon Cancer, Lung Cancer, Ovarian Cancer, Pancreatic Cancer, Hepatocellular Carcinoma... | 21 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06508307) |
| June 18, 2024 | NCT06465069 | A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors | Eli Lilly and Company | Phase 1 | Recruiting | Metastatic Solid Tumor, Recurrent Solid Tumor, Advanced Solid Tumor, Urinary Bladder Neoplasm, Triple Negative Breast... | 460 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06465069) |
| June 6, 2024 | NCT06444815 | A Study of VET3-TGI in Patients With Solid Tumors | KaliVir Immunotherapeutics | Phase 1 | Recruiting | Solid Tumor, Adult, Microsatellite Stable Colorectal Cancer, Head and Neck Squamous Cell Carcinoma, Cervical Cancer... | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06444815) |
| May 6, 2024 | NCT06400472 | A Study of Sofe-M in Participants With Selected Advanced Solid Tumors | Eli Lilly and Company | Phase 1 | Recruiting | Ovarian Neoplasms, Endometrial Neoplasms, Uterine Cervical Neoplasms, Carcinoma, Non-Small-Cell Lung, Triple Negative... | 575 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06400472) |
| April 25, 2024 | NCT06383507 | A Clinical Study of Anti-CD70 UCAR-T in Relapsed or Refractory Solid Tumors | Zhejiang University | Phase 1 | Not yet recruiting | Metastatic Tumor, Advanced Solid Tumor, Renal Cell Carcinoma, Ovarian Cancer, Cervix Cancer, Head and Neck Squamous... | 18 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06383507) |
| April 10, 2024 | NCT06358053 | CRTE7A2-01 TCR-T Cells for HPV-16 Positive Advanced Cancers | Corregene Biotechnology Co., Ltd | Phase 1 | Not yet recruiting | Cervical Cancer, Anal Cancer, Head and Neck Cancers, Other Solid Tumors | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06358053) |
| March 18, 2024 | NCT06315257 | A Clinical Trial to Assess PVX7 Immunotherapy Regimens in Advanced Cervical Cancer Patients | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Phase 1 | Recruiting | Cervical Cancer | 32 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06315257) |
| March 13, 2024 | NCT06307925 | A Phase I Study to Evaluate the Safety, Pharmacokinetics and Antitumor Activity of HC010 in Patients With Advanced Solid Tumors | HC Biopharma Inc. | Phase 1 | Recruiting | Advanced Solid Tumor | 122 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06307925) |
| March 5, 2024 | NCT06293898 | Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors | SystImmune Inc. | Phase 1 | Recruiting | Endometrial Cancer, Cervical Cancer, Ovarian Cancer, Urothelial Carcinoma, Biliary Tract Cancer, Breast Cancer, Lung... | 280 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06293898) |
| February 5, 2024 | NCT06242470 | A Study of MGC026 in Participants With Advanced Solid Tumors | MacroGenics | Phase 1 | Recruiting | Advanced Solid Tumor, Advanced Cancer, Metastatic Cancer, Squamous Cell Carcinoma of Head and Neck, Non Small Cell Lung... | 394 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06242470) |
| January 30, 2024 | NCT06232083 | A Multi Tumor, Open Phase I Clinical Study on the Progression of First-line Anti-tumor Therapy Using Cardonizumab Combined With Pulsed... | Anhui Provincial Hospital | Phase 1 | Recruiting | Lung Cancer, Esophageal Cancer, Cervical Cancer | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06232083) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| M.D. Anderson Cancer Center | 2 |
| Tongji Hospital | 2 |
| SystImmune Inc. | 2 |
| Anhui Provincial Hospital | 2 |
| [Eli Lilly and Company](https://specstream.ai/data/clinical-trials/company/eli-lilly-and-company) | 2 |
| Therorna | 1 |
| Sutro Biopharma, Inc. | 1 |
| Nurix Therapeutics, Inc. | 1 |
| GONGCHU Biotechnology Co., Ltd | 1 |
| ViroMissile, Inc. | 1 |
| [MacroGenics](https://specstream.ai/data/clinical-trials/company/macrogenics) | 1 |
| UNC Lineberger Comprehensive Cancer Center | 1 |
| Suzhou BlueHorse Therapeutics Co., Ltd. | 1 |
| Zhejiang University | 1 |
| Kortuc, Inc. | 1 |
| The Affiliated Hospital of Qingdao University | 1 |
| Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 1 |
| [Seagen, a wholly owned subsidiary of Pfizer](https://specstream.ai/data/clinical-trials/company/seagen-a-wholly-owned-subsidiary-of-pfizer) | 1 |
| Huahui Health | 1 |
| University Medical Center Groningen | 1 |
| Regor Pharmaceuticals Inc. | 1 |
| HRYZ Biotech Co. | 1 |
| KaliVir Immunotherapeutics | 1 |
| Kivu Bioscience Inc. | 1 |
| Myeloid Therapeutics | 1 |

## By country

| Country | Trials |
| --- | --- |
| United States | 21 |
| China | 13 |
| Australia | 8 |
| United Kingdom | 5 |
| France | 4 |
| Spain | 4 |
| South Korea | 3 |
| Japan | 3 |
| Italy | 2 |
| India | 1 |
| Thailand | 1 |
| Switzerland | 1 |
| Taiwan | 1 |
| Netherlands | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Concierge medicine practices in the United States](https://specstream.ai/data/businesses/concierge-medicine-practices/united-states)
- [Public adjusters in the United States](https://specstream.ai/data/businesses/public-adjusters/united-states)
- [Distilleries in the United States](https://specstream.ai/data/businesses/distilleries/united-states)
- [Sandblasting companies in the United States](https://specstream.ai/data/businesses/sandblasting-companies/united-states)
- [EMS training centers in the United States](https://specstream.ai/data/businesses/ems-training-centers/united-states)
- [Spices wholesalers in the United States](https://specstream.ai/data/businesses/spices-wholesalers/united-states)
